Trends in Opioids Prescribed at Discharge From Emergency Departments Among Adults: United States, 2006–2017
Examines trends in emergency department (ED) discharge opioid prescribing for adults from 2006–2007 through 2016–2017. Provides data by selected patient and hospital characteristics and the type of opioids prescribed. Table 1 includes data on the percent of ED patients prescribed an opioid at discharge by location of patient residence for metropolitan and nonmetropolitan areas.
Author(s): Pinyao Rui, Loredana Santo, Jill J. Ashman
Date: 01/2020
Type: Document
Sponsoring organization: National Center for Health Statistics
view details

Opioid Prescribing Among Adults With Disabilities in the United States After the 2014 Federal Hydrocodone Rescheduling Regulation
Examines the impact of the 2014 federal rescheduling regulation regarding hydrocodone-combination products on Medicare beneficiaries with disabilities. Provides maps of prolonged opioid use by Medicare beneficiaries with disabilities by state before and after the regulation was implemented. Includes data analysis of beneficiaries in metropolitan, urban, and rural areas.
Author(s): Victor Law, Yong-Fang Kuo, Mukaila A. Raji, Jacques Baillargeon
Citation: Public Health Reports, 135(1), 114-123
Date: 12/2019
Type: Document
view details

340B Drug Discount Program: Increased Oversight Needed to Ensure Nongovernmental Hospitals Meet Eligibility Requirements
Provides an overview of the Government Accountability Office's (GAO) review of 258 nongovernmental hospitals that participate in the 340B Drug Pricing Program and their contracts with state and local governments. Evaluates the contracts to determine if they meet the eligibility requirement to serve low-income individuals. Outlines weaknesses in the Health Resources and Services Administration's review of the hospital contracts and offers six recommendations to improve the contract review process.
Additional links: Full Report
Date: 12/2019
Type: Document
Sponsoring organization: Government Accountability Office
view details

Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use Disorder
Results of a cross-sectional county-level study using all reported direct-to-physician pharmaceutical payments from manufacturers of opioid use disorder medications from 2014-2017, as well as demographic and economic data from 3,140 counties. Features statistics with breakdowns by metropolitan, micropolitan, and rural areas.
Author(s): Thuy Nguyen, Barbara Andraka-Christou, Kosali Simon, W. David Bradford
Citation: JAMA Network Open, 2(12)
Date: 12/2019
Type: Document
view details

Opioid-Related Hospitalization and Its Association With Chronic Diseases: Findings From the National Inpatient Sample, 2011-2015
Results of a study examining whether opioid-related hospitalization is associated with cancer, stroke, obesity, asthma, liver or spinal disease, and arthritis. Features demographic statistics with breakdowns by urban or rural location.
Author(s): Janani Rajbhandari-Thapa, Donglan Zhang, Heather M. Padilla, Sae Rom Chung
Citation: Preventing Chronic Disease, 16
Date: 11/2019
Type: Document
view details

Rural-Urban Disparities in Health Care in Medicare
Examines rural/urban differences in the quality of healthcare received by Medicare beneficiaries in 2018, with breakdowns by race and ethnicity. Focuses on patient experience and clinical care measures, including screening for and management of health conditions and medication-related issues.
Date: 11/2019
Type: Document
Sponsoring organization: Centers for Medicare and Medicaid Services
view details

Analysis of Buprenorphine Prescribing Patterns Among Advanced Practitioners in Medicaid
Presentation slides from an October/November 2019 public meeting, describing the effects of the Comprehensive Addiction and Recovery Act of 2016 on access to opioid use disorder treatment for Medicaid beneficiaries. Includes information on urban and rural trends in prescribing.
Author(s): John Wedeles
Date: 10/2019
Type: Presentation Slides
Sponsoring organization: Medicaid and CHIP Payment and Access Commission
view details

Delta Region Community Health Systems Development (DRCHSD) Program: 340B Drug Pricing Program Guide
Provides rural hospital administrators with information regarding the 340B Drug Pricing Program. Offers State Offices of Rural Health (SORHs) directors and Flex Program coordinators a better understanding of the process hospitals must abide by to participate in the 340B Program.
Author(s): BKD CPAs & Advisors
Date: 10/2019
Type: Document
Sponsoring organization: National Rural Health Resource Center
view details

Medicare Payment Basics: Part D Payment System
Overview of the Medicare Part D prescription drug benefit including subsidy amounts, payments to plans, and how enrollee premiums are calculated.
Date: 10/2019
Type: Document
Sponsoring organization: Medicare Payment Advisory Commission
view details

Electronic Prescribing of Controlled Substances among Office-Based Physicians, 2017
Examines rates of electronic prescribing of controlled substances (EPCS), with information by type of physician practice, including rural or urban location, practice size, practice ownership, physician specialty, and technology available. EPCS is mandated for Medicare Part D providers by 2021, through the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.
Author(s): Sonal Parasrampuria, Martin Blanco, Wesley Barker
Date: 09/2019
Type: Document
Sponsoring organization: Office of the National Coordinator for Health Information Technology
view details